FdaApplication
ANDA 213293
Identifiers
- fda_app_no: ANDA213293
Properties
| Property | Value |
|---|---|
| applicant_name | INVAGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2021-08-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PENICILLAMINE | PENICILLAMINE | 250MG | CAPSULE;ORAL |
1 product